Alfredo J Lucendo
Overview
Explore the profile of Alfredo J Lucendo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
212
Citations
4819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lucendo A, Gutierrez-Ramirez L, Tejera-Munoz A, Molina-Infante J, Arias A
Clin Gastroenterol Hepatol
. 2025 Mar;
PMID: 40089255
Background & Aims: Proton pump inhibitor (PPI) therapy results in clinical and histological remission in approximately 50% of eosinophilic esophagitis (EoE) patients. We aimed to systematically update this topic due...
2.
Casas Deza D, Alcedo J, Lafuente M, Lopez F, Perez-Aisa A, Pavoni M, et al.
Am J Gastroenterol
. 2025 Feb;
PMID: 39902822
Introduction: To evaluate the prescription patterns, effectiveness, and safety of adding probiotics to Helicobacter pylori eradication therapy, in Europe. Methods: International, prospective, noninterventional registry of the clinical practice of the...
3.
Grueso-Navarro E, Rodriguez-Alcolado L, Arias-Gonzalez L, Aransay A, Lozano J, Sidorova J, et al.
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859353
Eosinophilic esophagitis (EoE) is a chronic inflammatory esophageal disorder. The lack of non-invasive biomarkers currently results in dependency on endoscopy with biopsies for its diagnosis and monitoring. We aimed to...
4.
Gisbert J, Donday M, Riestra S, Lucendo A, Benitez J, Navarro-Llavat M, et al.
Gut
. 2025 Jan;
74(3):387-396.
PMID: 39794921
Background And Objectives: Primary objectives: to compare the rates of sustained clinical remission at 12 months in patients treated with antitumour necrosis factor (anti-TNF) and immunomodulators who withdraw anti-TNF treatment...
5.
Giordano A, Perez-Martinez I, Gisbert J, Ricart E, Martin-Arranz M, Mesonero F, et al.
Am J Gastroenterol
. 2025 Jan;
120(1):194-203.
PMID: 39745305
Introduction: Crohn's disease (CD) varies by location, potentially affecting therapy efficacy and surgery risk, although research on this topic is conflicting. This study aims to investigate the independent association between...
6.
Biedermann L, Schlag C, Straumann A, Lucendo A, Miehlke S, Vieth M, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39694205
Background & Aims: Budesonide orodispersible tablets (BOT) have been shown to be safe and effective in phase III double-blind trials of induction and 48-week maintenance therapy of eosinophilic esophagitis (EoE)....
7.
Lucendo A, Nantes-Castillejo O, Straumann A, Biedermann L, Bredenoord A, Guagnozzi D, et al.
Aliment Pharmacol Ther
. 2024 Dec;
61(3):444-455.
PMID: 39676687
Background: EsoCap is a thin mucoadhesive film designed to target the oesophageal mucosa. The device loaded with mometasone furoate (ESO-101) is under investigation for the treatment of eosinophilic oesophagitis (EoE)....
8.
Laserna-Mendieta E, Casabona-Frances S, Amorena E, Savarino E, Perez-Martinez I, Blas-Jhon L, et al.
United European Gastroenterol J
. 2024 Nov;
12(10):1388-1398.
PMID: 39513462
Background: Eosinophilic esophagitis (EoE) predominantly affects males across all ages; however, little is known about sex differences for other aspects of EoE. Objective: To investigate associations between sex and clinical...
9.
Olmedo L, Calvet X, Gene E, Bordin D, Voynovan I, Castro-Fernandez M, et al.
Gut
. 2024 Oct;
74(1):15-25.
PMID: 39461739
Background: Bismuth quadruple therapies (BQTs) including bismuth, a proton pump inhibitor (PPI) and two antibiotics have been shown to be highly effective for treating infection even in areas of high...
10.
Fuentes-Valenzuela E, Delgado-Guillena P, Velamazan-Sandalinas R, Sanchez J, Garcia-Morales N, Barrio J, et al.
Gastroenterol Hepatol
. 2024 Sep;
47(8):901-905.
PMID: 39349042
No abstract available.